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Multicellular organisms are continuously exposed to
many different pathogens. Because different classes
of pathogens require different types of immune
responses, understanding how an ongoing immune
response to one type of infection affects the host’s
ability to respond to another pathogen is essential
for a complete understanding of host-pathogen
interactions. Here, we used a mouse model of coin-
fection to gain insight into the effect of respiratory
influenza virus infection on a subsequent systemic
bacterial infection. We found that influenza infection
triggered a generalized stress response leading to
a sustained increase in serum glucocorticoid levels,
resulting in a systemic suppression of immune
responses. However, virus-induced glucocorticoid
production was necessary to control the inflamma-
tory response and prevent lethal immunopathology
during coinfection. This study demonstrates that
activation of the hypothalamic-pituitary-adrenal
axis controls the balance between immune defense
and immunopathology and is an important compo-
nent of the host response to coinfection.
INTRODUCTION
Most studies of host-pathogen interactions have focused on the
interaction of a single pathogen with a host cell or organism.
However, host organisms in a natural environment are
commonly exposed to multiple pathogens simultaneously. The
immune response to infection can cause vast physiological alter-
ations in the metazoan host, including changes in metabolism,
serum proteins, cellular distribution, and hematopoiesis. In addi-
tion, the class of pathogen and the site of infection are instru-
mental in determining the extent and type of immune response
induced. Therefore, an important problem in host-pathogen
interactions is how the immune response to one pathogen alters
the immune response to another infectious agent (Bakaletz,
2004). Polymicrobial infection, or coinfection, can lead to compli-
cations in the treatment of infectious diseases, and there areCell Hostmany well-recognized instances of coinfection that occur natu-
rally in the human population (Beadling and Slifka, 2004; Elston
and Thaker, 2008; Re´nia and Potter, 2006). Several studies
examining infection with bacteria during an ongoing response
to a viral infection have found that, depending on the types of
pathogens, the temporal proximity of the infections, and the
route of infection, a variety of outcomes are possible (Barton
et al., 2007; Gardner, 1981; Gumenscheimer et al., 2007; Hum-
phreys et al., 2008; Navarini et al., 2006). Respiratory infection
with influenza virus is particularly interesting in this regard, as it
is most commonly complicated by secondary bacterial infec-
tions (Hament et al., 1999).
Influenza virus is a negative-stranded RNA virus that primarily
infects the lung epithelium and leads to a strong local inflamma-
tory response (La Gruta et al., 2007). Infection with influenza virus
in humans usually leads to a brief but severe illness, and fatalities
are often linked to coinfection with bacterial pathogens (Beadling
and Slifka, 2004; Berendt and Jaax, 1985; Hament et al., 1999;
McCullers, 2006; Peltola and McCullers, 2004; Seki et al.,
2004; Sun and Metzger, 2008). Several studies have demon-
strated that infection with influenza virus can result in immuno-
suppression and subsequent secondary bacterial infection
(Borrow et al., 2005; Didierlaurent et al., 2008; Marcus et al.,
2005; Noone et al., 2005; Shahangian et al., 2009; Sun and
Metzger, 2008; Tumpey et al., 2000; van der Sluijs et al., 2004).
However, these studies focused primarily on the local effects
of influenza at the site of infection. The effect of influenza
virus infection on the systemic immune response is less well
understood.
Influenza virus infection facilitates the ability of bacterial path-
ogens to gain entry and replicate in the lung, and many of these
pathogens are able to spread systemically with lethal complica-
tions (Beadling and Slifka, 2004). In order to specifically examine
the effect of influenza virus lung infection on the systemic
immune response to bacteria, we utilized the model bacterial
pathogen L. monocytogenes. Although L. monocytogenes is
not commonly associated with secondary bacterial infections
during influenza infection, it was used here because it provides
an excellent model of a systemic bacterial infection. The innate
immune system is triggered rapidly after infection with L. mono-
cytogenes, and it is crucial for early control of bacterial replica-
tion (Kaufmann, 1993). Two cytokines are important components
of the innate immune response to L. monocytogenes, IL-6 and
IFN-g (Andersson et al., 1998; Dai et al., 1997; Dalrymple et al.,& Microbe 7, 103–114, February 18, 2010 ª2010 Elsevier Inc. 103
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Figure 1. Bacterial Burden Is Increased in Influenza Virus-Infected
Mice
(A) Mice infected with influenza virus were infected with L. monocytogenes
1 day later, and 4 days after bacterial infection, cfu per gram of organ were
determined for the spleen and the liver.
(B) Mice were infected with 1000 pfu of influenza virus 1, 3, or 5 days before
infection with L. monocytogenes, and cfu were determined 4 days after bacte-
rial infection.
(C) Mice were infected with 200 pfu of influenza virus 5 days before infection
with L. monocytogenes, and cfu were determined 8 days after bacterial infec-
tion. Data are from at least two independent experiments with at least four
mice in each group (*p % 0.05, **p % 0.001, ***p % 0.0001, no *p > 0.05).
See also Figure S1.
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Influenza Virus-Induced Immunosuppression1995; Kopf et al., 1994). The primary cells infected by L. mono-
cytogenes are macrophages and hepatocytes (Selmi et al.,
2007). Following infection, bacteria spread from cell to cell by
co-opting the host cell’s actin-based motility system (Portnoy
et al., 2002). As with many systemic bacterial infections, the
hepatic immune response is essential for the clearance of
L. monocytogenes (Cousens and Wing, 2000; Selmi et al.,
2007). The early immune response in the liver consists primarily
of interactions between the resident hepatocytes and Kupffer
cells and infiltrating monocytes and neutrophils (Gregory and
Wing, 2002). While the innate immune response is able to control
many aspects of L. monocytogenes infection, the adaptive
immune system, and particularly the cytotoxic T cell response,
is necessary for sterilizing immunity to the pathogen (Pamer,
2004; Unanue, 1997b).
We found that influenza infection suppressed the systemic
antibacterial innate immune response. The major mechanism
for this suppression was influenza virus infection-induced gluco-
corticoid (GC) production. GCs are produced by adrenal glands
during times of psychological and physiological stress, and their
production is regulated by the hypothalamic-pituitary-adrenal
(HPA) axis (Di Comite et al., 2007; Rogatsky and Ivashkiv,
2006; Sternberg, 2006). They are known to have pleiotropic
immunosuppressive effects and are important in regulating
inflammation (Sternberg, 2006). Previous studies that demon-
strated production of GCs during viral infection and other
inflammatory immune responses proposed mechanisms of GC
production caused by inflammatory cytokines such as IL-1 and
IL-6 (Besedovsky and del Rey, 1989; Bethin et al., 2000; Dunn
et al., 1989; Dunn and Vickers, 1994; Hermann et al., 1994;
Ruzek et al., 1997). We show here that lung infection with
influenza virus can induce GC production independently of
elevated systemic inflammatory cytokines. Furthermore, we
show that while GC production resulted in systemic immunosup-
pression, it was required to protect coinfected hosts from lethal
immunopathology.
RESULTS
Coinfection with Influenza and L. monocytogenes
Results in Increased Bacterial Burden
To examine the effect of an ongoing viral infection on the immune
response to a systemic bacterial infection, C57BL/6 mice were
infected intranasally with influenza virus and subsequently in-
fected intravenously with L. monocytogenes. Bacterial and viral
loads were measured in the liver and spleen 4 days after
L. monocytogenes infection. Mice with a concurrent viral infec-
tion had a five-log greater bacterial load in the liver compared
to mice infected with L. monocytogenes alone (Figures 1A and
1B). This increase in bacterial burden was dependent on the
dose of influenza virus (Figure 1A). The minimal effective influ-
enza virus dose caused an increase in bacterial cfu even when
given as many as 5 days before L. monocytogenes (Figure 1B).
A lower dose of virus (200 pfu) was effective in causing an
increased bacterial load only when given 3–5 days before bacte-
rial infection (Figure 1C and data not shown). Mice infected with
a sublethal viral dose of 200 pfu 5 days before infection with
L. monocytogenes also displayed delayed bacterial clearance
when examined 8 days after bacterial infection (Figure 1C).104 Cell Host & Microbe 7, 103–114, February 18, 2010 ª2010 ElsevMice given this sublethal dose of influenza had elevated levels
of bacteria in the liver 4, 6, 8, and 12 days after bacterial infection
and in the spleen at the later time points (Figure S1). However, by
30 days after bacterial infection, the bacteria were cleared in
both organs regardless of a previous infection with influenza
virus (data not shown).
Type I IFNs have been shown to be detrimental to the host
response during L. monocytogenes infection (Auerbuch et al.,
2004; Carrero et al., 2004; Decker et al., 2005; O’Connell et al.,
2004). Given that type I IFNs are produced during the early
stages of an active influenza virus infection (Julkunen et al.,
2001; Wang et al., 2000), it seemed possible that this was
responsible for the increased cfu. However, type I IFNs were
not responsible for the increase in bacterial cfu observed in co-
infected mice, as there was still a significant increase in cfu in
viral/bacterial coinfected IFNaR1-deficient mice (Figure 2A).ier Inc.
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Figure 2. Bacterial Burden Is Increased inCoinfected IFNaR1/ and
Rag2/ Mice
(A and B) Bacterial cfu were measured in the liver and spleen 4 days after infec-
tion with L. monocytogenes in IFNaR1/ (A) or Rag2/ (B) mice that were in-
fected with 1000 pfu of influenza virus.
(C) Viral titers were measured in the lungs of C57BL/6 mice infected with
100,000 pfu and IFNaR1/ or Rag2/ mice that were infected with 1000
pfu of influenza virus. Data in (A) and (B) are from at least three independent
experiments with at least three mice in each group, and data in (C) are from
two independent experiments with at least three mice in each group (*p %
0.05, **p% 0.001, no *p > 0.05). See also Figure S2.
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with influenza virus was observed as early as 4 days after infec-
tion with L. monocytogenes, suggesting a defect in the innate
immune response. We examined further whether this increased
bacterial burden was due to altered functions of the innate or
acquired immune system by infecting Rag2/ mice, which
lack an acquired immune system. Rag2/ coinfected mice ex-
hibited increases in bacterial load that were similar to those
observed in coinfected wild-type mice (Figure 2B), indicating
that the acquired immune response was not responsible for
the initial increase in cfu.
Since both type I IFNs and cells of the acquired immune
system are necessary components of the antiviral immune
response, both IFNaR1/ andRag2/mice had increased viral
loads in the lungs when infected with the same dose of influenzaCell Hostas wild-type mice (data not shown). To compare the effect of
influenza on subsequent bacterial infection in wild-type,
IFNaR1/, and Rag2/ mice independent of this increased
viral load, viral doses were used that resulted in similar viral loads
in the lungs of all strains of mice (Figure 2C). As shown in
previous studies (Garcı´a-Sastre et al., 1998), influenza virus
had altered tissue tropism in IFNaR1/ mice and spread
systemically to the kidneys (data not shown). While influenza
virus infection had a profound effect on the bacterial burden,
infection with L. monocytogenes did not alter the tissue tropism
or viral titer of the influenza virus in comparison with singly
infected controls (Figure 2C and data not shown).
Infection with Influenza Suppresses the Immune
Response to L. monocytogenes
Since coinfection with influenza virus and L. monocytogenes led
to increased bacterial burden, we next examined the immune
response to L. monocytogenes after infection with influenza
virus. One clear change was that the spleen size and total sple-
nocyte number of both influenza virus-infected and coinfected
mice was decreased compared to spleens of uninfected mice
or mice infected with L. monocytogenes alone (Figure 3A).
Systemic levels of inflammatory cytokines were also measured
over the course of L. monocytogenes infection. When compared
to mice infected with L. monocytogenes alone, the levels of
IFN-g and IL-6 in the serum were significantly decreased in
coinfected mice (Figure 3B).
Since increased bacterial loads were observed mainly in the
liver, we next directly examined the hepatic immune response.
Recruitment of leukocytes to the liver by chemokines, cytokines,
and adhesion molecules is essential for development of an
appropriate immune response (Salmi et al., 1998). We therefore
examined liver sections from mice 4 days postinfection with
L. monocytogenes for recruitment of immune cells. There was
a significant decrease in cellular infiltrate in the livers of coin-
fected mice compared to mice infected with Listeria monocyto-
genes alone (Figures 3C and S3A). At day 1 after bacterial
infection, there was a significant decrease in neutrophil infiltrate
(Figures S3B and S3C).
To examine a cause for this reduction in leukocyte infiltrates,
we looked at the expression of chemokines in the liver. We
observed significant decreases in expression levels of the che-
mokines CCL7 (MCP-3), CCL2 (MCP-1), CXCL10 (IP-10),
CXCL2 (MIP-2a), and CXCL9 (MIG) in coinfected mice relative
to mice infected with bacteria alone (Figure 3D). CXCL10 and
CXCL9, two chemokines with proposed bactericidal activity,
are both induced by IFN-g (Cole et al., 2001); it is therefore
possible that reduction in systemic IFN-g may account for their
decreased expression in the liver. CCL2 and CCL7 have both
been shown to be critical chemokines in the defense against
L. monocytogenes (Jia et al., 2008). In addition, CCL7 can be
induced by IL-6; therefore, the reduction in systemic IL-6 may
lead to the decrease in hepatic CCL7 expression (Romano
et al., 1997). While CCL2 recruits mainly monocytes to the site
of infection, CCL7 attracts many different cell types of the
immune system by binding to at least four different chemokine
receptors (Menten et al., 2001). In addition to the decrease in che-
mokine expression, there was a decrease in the hepatic expres-
sion of the adhesion molecule Icam-1 (Figure 3D). The reduction& Microbe 7, 103–114, February 18, 2010 ª2010 Elsevier Inc. 105
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Figure 3. Influenza Virus Infection Causes Immunosuppression
(A) Splenocyte numbers were determined after infection with influenza and L. monocytogenes.
(B) The levels of the cytokines IFN-g and IL-6 in the serum were measured 1 and 4 days after infection with L. monocytogenes. Day 0 is prior to L. monocytogenes
infection and 1 day after influenza infection.
(C) The areas of infiltrating cells per field were determined by blind scoring of H&E-stained liver sections 4 days after infection with L. monocytogenes.
(D) Gene expression in the liver was determined at 1, 2, and 4 days after bacterial infection in mice infected with influenza alone, mice infected with L. monocy-
togenes alone, or coinfected mice. In all experiments, mice were infected with 10,000 pfu of influenza 1 day before infection with L.monocytogenes. Data are from
at least three independent experiments with at least four mice in each group. The error bars represent SD (*p% 0.05, **p% 0.001, ***p% 0.0001, no *p > 0.05).
See also Figure S3.
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Influenza Virus-Induced Immunosuppressionof these critical chemokines and adhesion molecules in the liver is
consistent with the observed reduction of immune cell infiltrate.
Given the delay in bacterial clearance, it seemed likely that
aspects of the acquired immune response were also sup-
pressed. Indeed, there were fewer antigen-specific CD8+
T cells at day 8 after bacterial infection in mice infected 5 days
previously with 200 pfu of influenza virus (Figure S2). Thus,
previous infection with influenza virus suppresses many aspects
of the innate and acquired immune responses to systemic bacte-
rial infection, including production of cytokines, tissue-specific
chemokines, immune cell infiltration into the infected organs,
and antigen-specific T cell accumulation.
Influenza Virus-Induced GCs Cause
Immunosuppression
We next examined the mechanism responsible for the sup-
pressed immune response in coinfected mice. Levels of the
immunosuppressive cytokine IL-10 were not increased in the
serum of influenza-infected or coinfected mice (Figure S6A and106 Cell Host & Microbe 7, 103–114, February 18, 2010 ª2010 Elsevdata not shown). Although this does not formally exclude
a potential contributing role of IL-10, we examined other poten-
tial mechanisms of immunosuppression. Mice infected with
influenza virus showed sustained elevated levels of GCs in the
serum (Figure 4A). GCs are produced by the adrenal glands in
response to stress through activation of the HPA axis and are
known to have multiple immunosuppressive effects (Sternberg,
2006). Inflammatory cytokines are known to induce GC, and
indeed, high levels of the cytokines IL-6, IFN-g, and IL-12 were
detectable in the serum of the infected mice 24 hr after systemic
infection with L. monocytogenes (Figure S6B). However,
increased serum GC levels were only detectable in L. monocyto-
genes-infected mice at the peak of the innate immune response
to infection (24 hr), after which they quickly returned to normal
levels (Figure 4A). In contrast, mice infected with influenza virus
showed sustained levels of serum GCs (Figure 4A) despite the
absence of high levels of systemic inflammatory cytokines
(Figure S6A). Furthermore, influenza virus-induced GC levels
were not decreased in MyD88/, IL-6/, IL-1R/, TNF-a/,ier Inc.
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Figure 4. Influenza Virus-Induced GCs Cause Increased Bacterial
Burden
(A) Serum GC levels were measured in mice infected with influenza virus, mice
infected with L. monocytogenes, coinfected mice, and coinfected ADX mice.
Day 0 indicates serum GC levels prior to bacterial infection.
(B) Bacterial cfu per gram were determined in the liver (top) and the spleen
(bottom) 4 days after bacterial infection in sham-operated (SHAM) or adrenal-
ectomized (ADX) mice infected with L. monocytogenes or mice coinfected with
influenza and L. monocytogenes. In addition, cfu were measured in mice in-
fected with L. monocytogenes and treated daily with DEX.
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Cell Hostand IFNaR1/mice (Figure S4). Finally, systemic administration
of lipopolysaccharide (LPS) caused only modest and transient
induction of GCs, while poly I:C caused no induction at all
(data not shown). Collectively, these results suggest that the
sustained level of serum GCs induced by influenza virus infection
was independent of a systemic inflammatory response.
To examine the role of influenza infection-triggered GCs in the
suppression of immune responses to a systemic bacterial
infection, we took advantage of mice that had their adrenal
glands surgically removed. Consistent with the requirement for
adrenal glands in the production of GCs, adrenalectomized
(ADX) mice did not show an increase in serum GCs in response
to coinfection or influenza infection alone (Figure 4A). In addition,
many of the ADX mice had levels of GCs that were below the limit
of detection. Importantly, adrenalectomy reversed the effect of
influenza infection on the hepatic bacterial load in coinfected
mice, as the coinfected ADX mice had bacterial loads similar
to mice infected with L. monocytogenes alone (Figure 4B).
Viral titers in the lung were not statistically different between
coinfected, coinfected sham-operated, and coinfected ADX
(Figure 4C).
The improved clearance of bacteria in coinfected ADX mice
indicated that the influenza virus infection-induced production
of GCs is an important mechanism involved in suppression of
the immune system during coinfection. We next analyzed the
specific aspects of the innate immune response that could be
the targets of GC signaling. In contrast to coinfected mice or co-
infected sham-operated controls, coinfected ADX mice had
higher levels of IL-6 in the serum 24 hr after L. monocytogenes
infection (Figure 5A). The levels were similar to those seen in
mice infected with L. monocytogenes alone, consistent with
in vitro observations showing that IL-6 is regulated by GCs
(Ray and Sehgal, 1992). IL-6 has also been shown to induce
expression of CCL7 (Romano et al., 1997). In correlation with
the observed rescue of IL-6 production, there was an increase
inCCL7 expression in the liver (Figure 5B). In addition, in ADX co-
infected mice, Icam-1 expression in the liver was also restored to
nearly the same level as in mice infected with L. monocytogenes
alone (Figure 5C). In accordance with the rescue of CCL7 and
Icam-1 expression in the liver in ADX mice, coinfected ADX
mice had levels of immune cell infiltrate similar to mice singly in-
fected with L. monocytogenes (Figures 5D and S3C). Another
pronounced effect of influenza virus coinfection was the
decrease in spleen size. This effect was also due to GCs, as it
was eliminated in coinfected ADX mice (Figure 5E). Interestingly,
the effect of adrenalectomy did not extend to all proinflammatory
signaling pathways, as serum levels of IFN-g were not affected(C) Viral titers were measured in coinfected mice, coinfected SHAM mice, and
coinfected ADX mice. In all experiments, mice were infected with 10,000 pfu of
influenza 1 day before infection with L. monocytogenes. Data in (A) and (B) are
from at least three independent experiments with at least four mice in each
group, and data in (C) are from two independent experiments with three or
four mice in each group. Bacterial cfu comparing L. monocytogenes alone,
coinfected, and coinfected ADX was repeated in ten independent experi-
ments with statistically significant results in each individual experiment,
Mice with no detectable cfu are indicated by symbols on the x axis. The error
bars represent SD (*p% 0.05, **p% 0.001, ***p% 0.0001, no *p > 0.05). See
also Figure S4.
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Figure 5. Removal of GC Rescues Virus-Induced Immunosuppression
(A–C) Serum levels of IL-6 and IFN-g and hepatic expression of CCL7 (B) and Icam-1 (C) were determined 1 day after infection with bacteria in mice infected with
influenza virus, mice infected with L. monocytogenes, coinfected mice, coinfected SHAM mice, coinfected ADX mice, and L. monocytogenes-infected mice
treated with DEX.
(D and E) The amount of immune cell infiltrate into the liver (D) and spleen weight (E) were determined 4 days after bacterial infection in uninfected mice,
mice infected with single pathogens, coinfected mice, coinfected SHAM mice, coinfected ADX mice, and L. monocytogenes-infected mice treated with DEX.
(F) The cytokines TNF-a, IL-5, and IL-6 were measured in the serum 4 days after infection with L. monocytogenes, in mice that were infected with influenza and
L. monocytogenes, coinfected ADX mice, coinfected SHAM mice, and singly infected controls. Data are from at least three independent experiments with at least
four mice in each group. The error bars represent SD (*p% 0.05, **p% 0.001, ***p% 0.0001, no *p > 0.05). See also Figure S5.
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Figure 6. ADX Mice Succumb to Coinfection
(A) ADX mice infected with a sublethal dose of influenza virus (200 pfu) and 5
days later a sublethal dose of L. monocytogenes (5000 cfu) had decreased
survival compared to singly infected ADX mice, singly infected mice, or coin-
fected mice.
(B) The cytokines TNF-a and IL-12p40 were elevated in the serum of coin-
fected ADX mice as early as 1 day after bacterial infection. Data are from at
least two independent experiments with at least four mice in each group.
The error bars represent SD (*p % 0.05, ***p % 0.0001, no *p > 0.05). See
also Figure S6.
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IFN-g induced chemokines also were not rescued in coinfected
ADX mice (data not shown). However, given the rescue of the
bacterial burden in ADX mice, the levels of these chemokines
and cytokines must be sufficient.
Further corroborating the hypothesis that virus-induced GCs
were responsible for the increased bacterial load, mice treated
daily with the synthetic corticosteroid dexamethasone (DEX)
starting 1 day prior to infection with L. monocytogenes also
showed increased bacterial loads in the liver (Figure 4B). Also,
the immunosuppression by influenza-induced GCs was
mimicked by DEX treatment. CCL7 and Icam-1 expression in
the liver were decreased in mice treated with DEX, and there
was a corresponding decrease in cellular infiltrates (Figures
5B–5D). In addition, the spleens of L. monocytogenes-infected/
DEX-treated mice showed a decrease in size (Figure 5E). Impor-
tantly, the DEX levels used in these experiments were deter-
mined by a bioassay to be physiologically similar to the levels
of GCs measured during influenza infection (Figure S5).
These results show that GC production triggered by an infec-
tion with influenza virus led to a suppression of key aspects of the
innate immune response to L. monocytogenes, including the
production of IL-6 and the hepatic expression of CCL7 and
Icam-1. Suppression of these key factors of the innate immune
response resulted in an increased bacterial burden. Blockade
of GC production prevented the suppression of the innate
immune response and reduced the early bacterial load in theCell Hostliver. In addition, treatment with DEX mimicked many of the
aspects of immunosuppression of the innate immune response
to L. monocytogenes caused by infection with influenza virus.ADX Coinfected Mice Have an Increased Inflammatory
Response and Decreased Survival
While many aspects of the influenza-induced immunosuppres-
sion, including the defect in bacterial clearance, were rescued
in ADX mice, prevention of GC production is not universally
beneficial to the host. Indeed, GCs are known to play an
important role in controlling excessive inflammation. Accord-
ingly, coinfected ADX mice had large increases in the systemic
inflammatory cytokines, IL-6, IL-5, and TNF-a, 4 days after
infection with L. monocytogenes and 5 days after infection
with influenza virus (Figure 5F). To examine the effect of the
increased inflammatory response further, mice were infected
with a sublethal dose of influenza virus, followed 5 days later
by a sublethal dose of L. monocytogenes. While all non-ADX
mice survived coinfection, the majority of the coinfected ADX
mice did not survive past 5 days after the bacterial infection,
and many started to succumb as early as 1 day after bacterial
infection (Figure 6A). In contrast, both ADX and non-ADX mice
infected with a sublethal dose of either L. monocytogenes
(5000 cfu) or influenza virus (200 pfu) alone were able to survive
for up to 30 days after infection (Figure 6A and data not
shown).
When we further examined this sudden decrease in survival of
the coinfected ADX mice, we found that there was a systemic
increase in two key inflammatory cytokines. There was a large
increase in serum levels of TNF-a and IL-12p40 1 day after
infection with L. monocytogenes in coinfected ADX mice, as
compared to the singly infected controls (Figure 6B). Both
TNF-a and IL-12p40 are known to be suppressed by GCs
(Rogatsky and Ivashkiv, 2006).
Since our coinfected mice were infected with influenza virus
for 5 days before infection with L. monocytogenes, it seemed
likely that there would also be significant alterations specifically
in the pulmonary immune response. There were large increases
in a number of inflammatory cytokines in the bronchoalveolar
lavage fluid (BALF) (Figure 7A). IL-6, IL-12p40, TNF-a, and
IFN-g were all increased in coinfected ADX mice to a greater
extent than any other group (Figure 7A). IL-1b and IL-5 were
increased in influenza-infected ADX mice and coinfected
ADX mice (Figure 7A). These cytokines are all known to be
subject to control by GCs (Besedovsky et al., 1986; Ray and
Sehgal, 1992). In addition, there was a dramatic increase in
immunopathology noted in the lungs of influenza-infected and
coinfected ADX mice (Figures 7B and S7). There was also an
increased level of albumin in the BALF of coinfected ADX mice,
which suggests increased epithelial tissue damage (Figure 7C).
In contrast, there were no detectable changes in the liver deter-
mined by histological analysis and expression of inflammatory
genes (data not shown).
Thus, while the production of GCs triggered by influenza virus
infection transiently suppressed the immune response to
a secondary bacterial infection, it was necessary to control the
inflammatory response during coinfection in order to prevent
lethal immunopathology.& Microbe 7, 103–114, February 18, 2010 ª2010 Elsevier Inc. 109
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Figure 7. Lack of GC Causes Increased
Inflammation and Immunopathology
(A) Coinfected ADX mice have increased levels of
IL-1b, IL-12p40, IL-6, IL-5, TNF-a, and IFN-g in
the bronchoalveolar lavage fluid (BALF).
(B) Coinfected ADX mice had increased lung
pathology.
(C) As a marker for epithelial cell damage, albumin
was measured in the BALF, and this was also
increased in coinfected ADX mice. Data are from
at least two independent experiments with at least
four mice in each group. The error bars represent
SD (*p % 0.05, **p % 0.001, no *p > 0.05). See
also Figure S7.
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The immune system undergoes a series of dramatic changes
during a response to infection. Exposure to a secondary infection
while the host undergoes these alterations may affect host
defense capabilities in multiple ways, depending on the types
of infections. Influenza virus infection is known to increase
susceptibility to secondary bacterial infections, particularly
opportunistic bacterial pathogens of the respiratory tract
(Beadling and Slifka, 2004). Many studies have focused on
mechanisms of influenza virus-mediated immunosuppression
in the lung (Didierlaurent et al., 2008; Shahangian et al., 2009;
Sun and Metzger, 2008; van der Sluijs et al., 2004). However,
the effect of influenza virus infection on systemic immunity is
less well understood. Many bacterial pathogens that initially
infect the lung will subsequently become systemic, and it is
therefore important to understand the impact of influenza virus
on the immune response to a systemic bacterial pathogen.
Here, we investigated how respiratory influenza infection affects
the systemic innate immune response. We chose the model
bacterial pathogen L. monocytogenes to investigate the effects
of influenza infection on subsequent systemic bacterial infection,
because the innate and adaptive immune responses to this path-110 Cell Host & Microbe 7, 103–114, February 18, 2010 ª2010 Elsevier Inc.ogen are well characterized (Pamer,
2004; Unanue, 1997a). Using this model
system, we found that influenza infection
caused a profound systemic immunosup-
pression, as indicated by a blunted
response to systemic infection with Liste-
ria. Specifically, we found decreased
production of inflammatory cytokines
and chemokines, reduced recruitment of
innate immune cells to the infection site
(liver), and, as a result, a dramatic
increase in bacterial burden. Surprisingly,
this systemic immunosuppressive effect
was mediated by a sustained production
of GCs triggered by the influenza infec-
tion. Surgical removal of the adrenal
glands, which are the main source of
GCs, eliminated most of the immunosup-
pressive effects of influenza infection.
Accordingly, ADX mice were able tobetter suppress secondary bacterial infection. Interestingly,
ADX mice had a relatively normal immune response to single viral
or bacterial infections. However, the lack of the GC response in
coinfected mice, while allowing for an improved antibacterial
immunity, eventually resulted in an exacerbated inflammatory
response, leading to lethality.
GCs are crucial for the homeostatic regulation of many phys-
iological systems (Tasker, 2006; Viegas et al., 2008). In the
immune response, they function to regulate inflammation and
maintain immune homeostasis (Di Comite et al., 2007; Stern-
berg, 2006). GCs are produced by adrenal glands through acti-
vation of the HPA axis by different types of psychological and
physiological stress (Di Comite et al., 2007; Rogatsky and
Ivashkiv, 2006; Ruzek et al., 1999). One type of physiological
stress that activates the HPA axis is excessive production of
inflammatory cytokines during systemic inflammatory response
syndrome (SIRS) (Beishuizen and Thijs, 2003; Webster and
Sternberg, 2004). Many bacterial and viral infections have been
shown to trigger the HPA axis because of an increase in systemic
inflammatory cytokines, and often the resulting GCs are neces-
sary to prevent an excessive inflammatory response (Besedov-
sky et al., 1986; Besedovsky and del Rey, 1989; Dunn and Vick-
ers, 1994; Hermann et al., 1994; Ruzek et al., 1997, 1999). In this
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Influenza Virus-Induced Immunosuppressionstudy, we demonstrate that infection with influenza virus induces
a sustained production of GCs in the absence of systemic
inflammation. In addition, we show that in mice deficient in the
classic inflammatory components that are known to induce
GCs (Silverman et al., 2005), influenza virus infection still induces
GC production, while a potent inflammatory response induced
by systemic administration of LPS or poly I:C did not result in
the same magnitude or duration of GC production. Collectively,
these data suggest that lung infection with influenza virus
induces GCs through a pathway that is at least in part indepen-
dent of systemic inflammatory cytokines. Influenza virus causes
lung damage both directly, through viral infection of epithelial
cells, and indirectly, through induction of the inflammatory
response (La Gruta et al., 2007). Damage to a crucial organ,
such as the lung, causes a generalized stress response (Mendez
and Hubmayr, 2005), which can trigger GC production. We
therefore suggest that lung tissue damage caused by influenza
virus infection triggers the HPA response and GC production.
Tissue damage in this case may be perceived through the group
C nerve fibers, which play an essential role in monitoring tissue
homeostasis (Craig, 2002). However, the exact mechanism link-
ing infection-induced tissue damage to the HPA axis activation is
currently unknown.
The prolonged elevated GC levels triggered by influenza virus
infection affected several key aspects of the innate immune
response. Here, we show that the induction of the essential
cytokine IL-6 in response to L. monocytogenes infection was
suppressed by influenza virus-induced GCs. Several key
aspects of the hepatic immune response to bacterial infection
(Jia et al., 2008; Lo´pez et al., 1999) were also suppressed during
coinfection, including the chemokine CCL7 and the adhesion
molecule Icam-1. Correlating with the decrease in hepatic che-
mokine and adhesion molecule expression, there was a signifi-
cant decrease in infiltrating immune cells into the liver in coin-
fected mice.
Corroborating the data with virus-induced GCs, daily treat-
ment with the synthetic corticosteroid DEX also affected the
innate immune response in the liver. Mice treated daily with
DEX had increased bacterial cfu in the liver comparable to
mice infected with influenza virus. The specific aspects of the
antibacterial innate immune response that were suppressed in
influenza-infected mice and rescued in ADX mice were also sup-
pressed in mice treated with DEX. Mice pretreated with DEX and
infected with L. monocytogenes had decreased expression of
the chemokine CCL7, decreased expression of the adhesion
molecule Icam-1, and subsequent decreased cellular infiltration
into the liver.
We observed that the liver was the major target organ of early
immunosuppression and the site of increased bacterial burden in
response to influenza-induced endogenous GCs or exogenous
DEX. There are several factors that may contribute to this
organ-specific suppression. The liver is a very important organ
in the immune response to many bacterial infections of the blood
and is known specifically to be important in the innate immune
response to L. monocytogenes (Cousens and Wing, 2000; Ebe
et al., 1999; Lo´pez et al., 1999). Regulation of the immune
response by IL-6 is very important for the immune response in
the liver, and mice deficient in IL-6 have a greater defect in the
immune response of the liver than the spleen (Dalrymple et al.,Cell Host1995). The liver has a high expression of GC receptors, and this
expression can be upregulated during times of stress (Dong
et al., 1988; Turner et al., 2006). Also, in the liver, hepatocytes
as well as macrophages supportL.monocytogenesgrowth, while
in the spleen, growth occurs mainly in macrophages. The disap-
pearance of these niche cells in the spleen due to GC-induced
apoptosis is likely to offset the immunosuppressive effect. A
combination of these factors could account for the influenza
virus-induced increase in bacterial load specifically in the liver.
In this study, we also found that GCs are necessary to control
excessive inflammation during coinfection and prevent a lethal
immunopathology. ADX mice infected with sublethal levels of
influenza virus followed 5 days later by a sublethal dose of
L. monocytogenes succumb within days of the bacterial infec-
tion. These mice have some signs of slightly increased systemic
inflammation, such as elevated levels of the cytokines TNF-a and
IL-12p40 in the serum; however, the most dramatic effects of co-
infection were observed mainly in the lung. Many inflammatory
cytokines in the BALF are dramatically increased in coinfected
ADX mice. Consequently, the lungs of coinfected ADX mice
had increased signs of immunopathology, including excess
immune cell infiltrates and epithelial cell necrosis. ADX mice in-
fected with influenza virus alone also have increased inflamma-
tory responses in the lung, but these responses are further
increased in the coinfected ADX mice.
Bacterial complications from viral infections cause more
morbidity and mortality than viral infections alone (Beadling
and Slifka, 2004). We have delineated a mechanism by which
infection with influenza virus, through the induction of GCs, leads
to suppression of the systemic immune response to a secondary
bacterial infection and therefore an increased bacterial burden.
However, we also found that the induction of GCs is critical for
survival of coinfection. When infected with influenza virus and
L. monocytogenes, mice lacking the ability to produce GCs
had a greatly exacerbated inflammatory response, particularly
in the lung, and did not survive coinfection. Collectively, our find-
ings reveal the inflammation-independent activation of the HPA
axis by influenza virus infection and demonstrate its physiolog-
ical and pathological consequences for a systemic bacterial
coinfection.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) mice were obtained from the National Cancer Institute and the
Jackson Laboratory and were between 6 and 12 weeks of age. ADX mice
were obtained from Taconic Laboratories (Germantown, NY). All other mice
were bred in the Yale University School of Medicine animal facility in specific
pathogen-free conditions. GC levels in the serum were measured by the
animal healthcare service Antech. DEX was administered intraperitoneally at
a daily dose of 1 mg per mouse starting 1 day before infection. All experiments
were performed in accordance with the institutional animal care and use
guidelines.
Bacterial and Viral Strains
The A/WSN/33 (H1N1) strain of influenza virus was obtained from the labora-
tory of Akiko Iwasaki and propagated using MDCK cells as described in Okuda
et al. (2001). The 10403S L.monocytogenes strain used was propagated in BHI
agar as described in Auerbuch et al. (2004). Influenza virus was administered
intranasally at the indicated doses in a volume of 30 ml. Mice were infected with
L. monocytogenes intravenously at the indicated doses in a volume of 100 ml.& Microbe 7, 103–114, February 18, 2010 ª2010 Elsevier Inc. 111
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Viral titers in the lungs were determined by titration of organ homogenates on
MDCK cells as described in Okuda et al. (2001). L. monocytogenes cfu were
determined by plating titrating doses of organ homogenate on agar plates
as previously described (Auerbuch et al., 2004).
Measurement of Cytokines and Chemokines
Briefly, tissues were disrupted in RNA-bee (Teletest; Friendswood, TX), and
RNA was isolated according to the manufacturer’s instructions. After treat-
ment with DNase, SuperScript III was used to produce cDNA. Quantitative
PCR was done on Eppendorf Mastercycler with QIAGEN SYBR Green mix
according to the manufacturer’s instructions. Serum cytokine levels
were measured using the Luminex system according to the manufacturer’s
instructions.
Tissue Histology
Organs used for histology were fixed overnight in Formalde-Fresh and
embedded in paraffin for sectioning. Sections were stained with H&E accord-
ing to the manufacturer’s instructions and blind-randomized scored. For each
liver section, 40 pictures were taken, and the areas of infiltrate were counted.
Statistical analysis was performed using the Prism graphing and analysis
software. Comparison of multiple groups was done using ANOVA, and
comparison of two groups was done with the Student’s t test.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at doi:10.1016/j.chom.2010.01.010.
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